Clinical Nutrition Research Center, Illinois Institute of Technology
Trial Pipeline
Optimizing Mango's Glycemic Impact: Investigating Mango Consumption Timing in Prediabetic Individuals
NCT06986161
MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors
NCT06555952
Vitamin and Mineral Absorption From Milk and PBMAs
NCT05898217
Watermelon Dose Response Blood Pressure Study
NCT05892328
Understanding Dose Related Effects of Strawberry
NCT06173765
Pulses Consumption and Its Role in Managing Systemic Inflammation, Insulin Sensitivity and Gut Microbiome in Human
NCT04267705
Berries, Inflammation, and Gut Microbiome
NCT04100200
Dietary Exchanges With Avocado and Mango in Pre-diabetes
NCT05353790
Food Containing Resistant Starch Type 4 and Postprandial Glycemic Response
NCT03844503
Longvida Curcumin Human Pharmacokinetics Study
NCT03289507
Different Types of Fruits on Metabolic Function and Cognitive Performance
NCT02736331
Absorption and Metabolic Profiles of a Sugar-based Beverage
NCT02226250
Fresh Fruit and Vegetable Purchasing Behavior
NCT01853514
Pasta Formulations, Portion Sizes and Their Effect on Appetite
NCT01199770
A Study of Tomato Products and Disease Risk
NCT00966550
Therapeutic Areas
What the Pipeline for Clinical Nutrition Research Center, Illinois Institute of Technology Shows
According to the ClinicalTrials.gov registry, Clinical Nutrition Research Center, Illinois Institute of Technology is linked to 15 US clinical trials across every stage of research activity. Of those, 2 studies are currently recruiting — about 13% of the sponsor's indexed portfolio — and 8 are already marked complete, representing roughly 53% of the total. Recruiting share is one of the more practical signals here: it reflects how much of a sponsor's research is presently open to new participants, while the completed share indicates the depth of finished work that has already contributed registry results. Both counts come directly from the public ClinicalTrials.gov dataset and are refreshed on the registry side; this page mirrors the latest data pull without altering it.
The phase mix for Clinical Nutrition Research Center, Illinois Institute of Technology reports 0 late-stage studies (Phase 3 and Phase 4 combined) and 0 earlier-phase studies (Phase 1 and Phase 2). A portfolio weighted toward Phase 3 usually reflects an organization advancing candidates toward regulatory review, where the research centers on comparative efficacy and broader safety across larger populations. A heavier Phase 1 and Phase 2 tilt generally indicates exploratory work — safety, dosing, and early signal detection — and is common among research-forward sponsors that seed many early programs. Phase 4 entries, when present, track interventions already in real-world use and typically focus on long-term safety, effectiveness across subgroups, or formulation comparisons.
The top therapeutic focus area indexed for Clinical Nutrition Research Center, Illinois Institute of Technology is Healthy with 7 linked trials, and 9 other condition areas appear in the top list above. That distribution is a quick read of where the organization concentrates its research attention; it does not imply product availability, market share, or any clinical endorsement. All numbers on this page come from ClinicalTrials.gov maintained by the National Library of Medicine, and counts can shift as new studies are registered or existing ones update their status. This information is provided for reference and educational purposes only, not as medical, investment, or regulatory advice — verify current details directly with ClinicalTrials.gov before relying on any figure here.
Read our methodology — how this data is sourced, computed, and verified.